生命科学资讯
生物技术与制药领域的最新动态
Imvax takes brain cancer cell therapy to FDA, betting survival hit will overshadow primary miss
Tiziana to spin out IL-6 drug into new company, citing Big Pharma's interest in modality
Novocure promotes new CEO, replacing current chief after less than a year
Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge
摩根士丹利开始覆盖安捷伦科技（A）——GuruFocus
Morgan Stanley Initiates Coverage on Agilent Technologies (A) wi - GuruFocus
Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug
TXG: Morgan Stanley Downgrades 10x Genomics, Raises Price Target - GuruFocus
Janux sinks on ‘overreaction’ to prostate cancer data; RFK Jr. replaces ACIP chair
As approval date looms, Cytokinetics gears up for David-and-Goliath battle with Bristol Myers
Trends and Tools Transforming Drug Discovery: Five Takeaways from Discover Glo 2025
Helicore stops work on clinical GIP antagonist after Phase 1 results
安捷伦科技股价受关键阻力位压制走低 - 今日预测 - 2025年2月12日 - Economies.com
Agilent Technologies price driven lower by pivotal resistance - Forecast today - 02-12-2025 - Economies.com
2020-2030年靶向测序行业洞察报告：重点介绍华大智造、GENEWIZ、安捷伦科技等领先企业概况 - 雅虎财经
Targeted Sequencing Industry Intelligence 2020-2030 Featuring Profiles of MGI Tech, GENEWIZ, Agilent Technologies and Other Leading Companies - Yahoo Finance